China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.34

(-0.43%)

Operating Income Summary of China Pioneer Pharma Holdings Limited

China Pioneer Pharma Holdings Limited's latest annual operating income in 2023 was 180.2 Million CNY , down -42.49% from previous year.
China Pioneer Pharma Holdings Limited's latest quarterly operating income in 2023 FY was 133.54 Million CNY , down -42.49% from previous quarter.
China Pioneer Pharma Holdings Limited reported an annual operating income of 232.18 Million CNY in 2022, up 24.01% from previous year.
China Pioneer Pharma Holdings Limited reported an annual operating income of 187.23 Million CNY in 2021, up 156.05% from previous year.
China Pioneer Pharma Holdings Limited reported a quarterly operating income of 133.54 Million CNY for 2023 FY, down -42.49% from previous quarter.
China Pioneer Pharma Holdings Limited reported a quarterly operating income of 44.55 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of China Pioneer Pharma Holdings Limited (2023 - 2010)

Historical Annual Operating Income of China Pioneer Pharma Holdings Limited (2023 - 2010)

Year	Operating Income	Operating Income Growth
2023	180.2 Million CNY	-42.49%
2022	232.18 Million CNY	24.01%
2021	187.23 Million CNY	156.05%
2020	73.12 Million CNY	-47.19%
2019	138.47 Million CNY	-7.47%
2018	149.65 Million CNY	-47.41%
2017	284.59 Million CNY	17.33%
2016	242.55 Million CNY	-6.87%
2015	260.45 Million CNY	-8.37%
2014	284.25 Million CNY	13.1%
2013	251.32 Million CNY	17.09%
2012	214.64 Million CNY	71.52%
2011	125.14 Million CNY	22.53%
2010	102.13 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2023 Q4	88.98 Million CNY	0.0%
2023 FY	133.54 Million CNY	-42.49%
2023 Q2	44.55 Million CNY	0.0%
2022 Q4	131.94 Million CNY	0.0%
2022 Q2	100.24 Million CNY	0.0%
2022 FY	232.18 Million CNY	24.01%
2021 FY	187.23 Million CNY	156.05%
2021 Q2	91.98 Million CNY	0.0%
2021 Q4	95.25 Million CNY	0.0%
2020 FY	73.12 Million CNY	-47.19%
2020 Q2	32.85 Million CNY	0.0%
2020 Q4	40.26 Million CNY	0.0%
2019 Q4	81.63 Million CNY	0.0%
2019 Q2	56.83 Million CNY	0.0%
2019 FY	138.47 Million CNY	-7.47%
2018 Q2	121.69 Million CNY	0.0%
2018 FY	149.65 Million CNY	-47.41%
2018 Q4	27.95 Million CNY	0.0%
2017 Q4	142.08 Million CNY	0.0%
2017 Q2	142.5 Million CNY	0.0%
2017 FY	284.59 Million CNY	17.33%
2016 Q4	125.09 Million CNY	0.0%
2016 Q2	117.46 Million CNY	0.0%
2016 FY	242.55 Million CNY	-6.87%
2015 FY	260.45 Million CNY	-8.37%
2015 Q2	160.24 Million CNY	0.0%
2015 Q4	100.2 Million CNY	0.0%
2014 FY	284.25 Million CNY	13.1%
2014 Q2	154.1 Million CNY	0.0%
2014 Q4	130.14 Million CNY	0.0%
2013 Q2	101.89 Million CNY	0.0%
2013 Q4	149.42 Million CNY	0.0%
2013 FY	251.32 Million CNY	17.09%
2012 Q4	71.94 Million CNY	32.66%
2012 Q2	54.23 Million CNY	0.0%
2012 Q3	54.23 Million CNY	0.0%
2012 Q1	54.23 Million CNY	0.0%
2012 FY	214.64 Million CNY	71.52%
2011 Q1	31.81 Million CNY	0.0%
2011 Q3	31.81 Million CNY	0.0%
2011 Q2	31.81 Million CNY	0.0%
2011 Q4	54.23 Million CNY	70.48%
2011 FY	125.14 Million CNY	22.53%
2010 FY	102.13 Million CNY	0.0%
2010 Q3	24.3 Million CNY	0.0%
2010 Q2	24.3 Million CNY	0.0%
2010 Q1	24.3 Million CNY	0.0%
2010 Q4	31.81 Million CNY	30.89%
2009 Q4	24.3 Million CNY	0.0%

Peer Operating Income Comparison of China Pioneer Pharma Holdings Limited

Name	Operating Income	Operating Income Difference
China Healthwise Holdings Limited	-112.57 Million HKD	260.075%
Tycoon Group Holdings Limited	336.55 Million HKD	46.454%
Beijing Tong Ren Tang Chinese Medicine Company Limited	624.14 Million HKD	71.127%